Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company LipoMedix Pharmaceutical Inc.
DescriptionPegylated liposomal mitomycin-C lipid-based prodrug
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today